One of Wall Street’s cardinal sins is a “set it and forget it” mentality. What I mean by that is there’s often a flurry of interest in specific stocks and then….nothing.

That’s too bad because the devil, as they say, is always in the details.

As we have discussed many times here at Total Wealth, you’ve got to check in on what you own periodically to ensure a given stock, bond, or ETF: a) still meets your objectives and risk tolerance, and b) that the reasons you bought it are still valid.

I call this the “ultimate trailing stop” simply because you want to make sure you’re on track not just when you buy something, but every day you own it.

So, in that spirit, let’s check in on two of our favorite Unstoppable Trend recommendations.

Both, I’m excited to report, remain compelling buys.

A New CEO Means New Business

Let’s start with Ekso Bionics Holdings Inc. (OTC:EKSO), our favorite Unstoppable Technology Trend play.

The company announced on Thursday that CEO Nathan Harding is stepping down after almost 13 years at the helm and that he is being replaced effective immediately by Ekso’s former president and chief commercialization officer Thomas Looby.

That’s a great move and one I’m happy to see.

Let me explain.

CEOs come and go for a variety of reasons. Sometimes it’s not under great circumstances, as was the case with former McDonald’s CEO, Don Thompson who left the then-struggling fast food giant under pressure in 2015.

But most of the time, particularly in young companies like Ekso, it’s a good thing because a changing of the guard means that the business is preparing itself for still greater things.

Apple, for example, has changed CEOs five times since 1977, not counting interim appointments due to Steve Jobs’ declining health. Each time, the shift has been to achieve still greater potential.